A novel ARDS therapeutic targeting the Ang1-Tie2 pathway and development of a companion diagnostic using machine learning to improve both the diagnosis and treatment of ARDS patients

Time: 9:40 am
day: Day One

Details:

  • Development of Ang1-C4bp: a novel therapeutic for ARDS
  • The importance of Ang1-Tie2 in ARDS treatment in both COVID and non-COVID patients
  • Collaboration between Mannin, DNAStack, Biosymmetrics to develop a novel companion diagnostic for ARDS utilizing machine learning
  • Discussion of clinical plans and timeline

Speakers: